IBDEI0P9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12381,1,3,0)
 ;;=3^Lt Eff Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,12381,1,4,0)
 ;;=4^438.9
 ;;^UTILITY(U,$J,358.3,12381,2)
 ;;=^269757
 ;;^UTILITY(U,$J,358.3,12382,0)
 ;;=284.9^^70^756^6
 ;;^UTILITY(U,$J,358.3,12382,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12382,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,12382,1,8,0)
 ;;=8^Aplastic Anemia,unspec
 ;;^UTILITY(U,$J,358.3,12382,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,12383,0)
 ;;=282.9^^70^756^12
 ;;^UTILITY(U,$J,358.3,12383,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12383,1,1,0)
 ;;=1^282.9
 ;;^UTILITY(U,$J,358.3,12383,1,8,0)
 ;;=8^Hemolytic Anemia,Hered
 ;;^UTILITY(U,$J,358.3,12383,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,12384,0)
 ;;=283.9^^70^756^10
 ;;^UTILITY(U,$J,358.3,12384,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12384,1,1,0)
 ;;=1^283.9
 ;;^UTILITY(U,$J,358.3,12384,1,8,0)
 ;;=8^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,12384,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,12385,0)
 ;;=283.0^^70^756^11
 ;;^UTILITY(U,$J,358.3,12385,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12385,1,1,0)
 ;;=1^283.0
 ;;^UTILITY(U,$J,358.3,12385,1,8,0)
 ;;=8^Hemolytic Anemia,Autoimmun
 ;;^UTILITY(U,$J,358.3,12385,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,12386,0)
 ;;=283.19^^70^756^13
 ;;^UTILITY(U,$J,358.3,12386,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12386,1,1,0)
 ;;=1^283.19
 ;;^UTILITY(U,$J,358.3,12386,1,8,0)
 ;;=8^Hemolytic Anemia,Microangiopathic
 ;;^UTILITY(U,$J,358.3,12386,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,12387,0)
 ;;=280.9^^70^756^14
 ;;^UTILITY(U,$J,358.3,12387,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12387,1,1,0)
 ;;=1^280.9
 ;;^UTILITY(U,$J,358.3,12387,1,8,0)
 ;;=8^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,12387,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,12388,0)
 ;;=281.0^^70^756^17
 ;;^UTILITY(U,$J,358.3,12388,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12388,1,1,0)
 ;;=1^281.0
 ;;^UTILITY(U,$J,358.3,12388,1,8,0)
 ;;=8^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,12388,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,12389,0)
 ;;=285.9^^70^756^20
 ;;^UTILITY(U,$J,358.3,12389,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12389,1,1,0)
 ;;=1^285.9
 ;;^UTILITY(U,$J,358.3,12389,1,8,0)
 ;;=8^Unspecified Anemia
 ;;^UTILITY(U,$J,358.3,12389,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,12390,0)
 ;;=281.8^^70^756^16
 ;;^UTILITY(U,$J,358.3,12390,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12390,1,1,0)
 ;;=1^281.8
 ;;^UTILITY(U,$J,358.3,12390,1,8,0)
 ;;=8^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,12390,2)
 ;;=^267979
 ;;^UTILITY(U,$J,358.3,12391,0)
 ;;=285.21^^70^756^2
 ;;^UTILITY(U,$J,358.3,12391,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12391,1,1,0)
 ;;=1^285.21
 ;;^UTILITY(U,$J,358.3,12391,1,8,0)
 ;;=8^Anemia End-Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,12391,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,12392,0)
 ;;=285.22^^70^756^3
 ;;^UTILITY(U,$J,358.3,12392,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12392,1,1,0)
 ;;=1^285.22
 ;;^UTILITY(U,$J,358.3,12392,1,8,0)
 ;;=8^Anemia In Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,12392,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,12393,0)
 ;;=285.29^^70^756^4
 ;;^UTILITY(U,$J,358.3,12393,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12393,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,12393,1,8,0)
 ;;=8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,12393,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,12394,0)
 ;;=285.1^^70^756^1
 ;;^UTILITY(U,$J,358.3,12394,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12394,1,1,0)
 ;;=1^285.1
 ;;^UTILITY(U,$J,358.3,12394,1,8,0)
 ;;=8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,12394,2)
 ;;=^267986
